Sp164

PANEL DISCUSSION

Date
May 18, 2024
Explore related products in the following collection:


Tracks

Related Products

Thumbnail for INCORPORATING A GI EXPERT DIETITIAN IN A GI ACADEMIC CENTER (CASE STUDY/DEMO)
Thumbnail for EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY
EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY
INTRODUCTION: There is a lack of data on the efficacy of dietary therapies by IBS subtype (IBS-D, IBS-C, and IBS-M)…
Thumbnail for INCORPORATING A GI EXPERT DIETITIAN IN A GI PRIVATE PRACTICE (CASE STUDY/DEMO)
Thumbnail for Irritable Bowel Syndrome Clinical
Irritable Bowel Syndrome Clinical
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Copyright © 2025 Digestive Disease Week
Powered by Conexiant DXP